
News|Articles|May 18, 2016
Well Care Compounding Pharmacy Issues Recall
Author(s)Pharmaceutical Technology Editors
The company recalls products due to sterility concerns.
Advertisement
FDA announced on May 17, 2016 that Well Care Compounding Pharmacy (Las Vegas, NV) is voluntarily recalling sterile compounded products distributed between Jan. 1–April 29, 2016. The recall comes after an FDA inspection of the facility that resulted in sterility assurance concerns.
The company states in a
Source:
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
2
Application of Predictive Modeling in the Development of Amorphous Solid Dispersions
3
AAPS PharmSci 360: CMC Strategies, Part 1
4
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
5




